"10.1371_journal.pone.0046437","plos one","2012-10-02T00:00:00Z","Enrique Casalino; Bruno Bernot; Olivier Bouchaud; Chakib Alloui; Christophe Choquet; Elisabeth Bouvet; Florence Damond; Sandra Firmin; Aurore Delobelle; Beatrice Ename Nkoumazok; Guillaume Der Sahakian; Jean-Paul Viard; Olivier Zak Dit Zbar; Elisabeth Aslangul; Anne Krivine; Julie Zundel; Jade Ghosn; Patrice Nordmann; Yann-Erick Claessens; Tassadit Tahi; Bruno Riou; Agnès Gautheret-Dejean; Christine Katlama; Pierre Hausfater; Françoise Brun-Vézinet; Dominique Costagliola","AP-HP, Groupe Hospitalier Universitaire Paris Nord-Val de Seine, Service daccueil des Urgences, Paris, France; Université Denis-Diderot Paris 7, Paris, France; AP-HP, Hôpitaux Universitaire Paris Seine St Denis, CHU Avicenne, Service daccueil des Urgences, Bobigny, France; AP-HP, Hôpitaux Universitaire Paris Seine St Denis, CHU Avicenne, Service des Maladies Infectieuses et Tropicales, Bobigny, France; Université Paris 13, Bobigny, France; AP-HP, Hôpitaux Universitaire Paris Seine St Denis, CHU Avicenne, Laboratoire de virologie, Bobigny, France; AP-HP, Groupe Hospitalier Universitaire Paris Nord-Val de Seine, Service des maladies infectieuses et tropicales, Paris, France; AP-HP, Groupe Hospitalier Universitaire Paris Nord-Val de Seine, Laboratoire de Virologie, Paris, France; Université Denis-Diderot Paris 7, EA 4409, Paris, France; INSERM U943, Paris, France; UPMC Univ Paris 06 UMR S943, Paris, France; AP-HP, Hôpital Hôtel-Dieu, Service daccueil des Urgences/SMUR, Paris, France; Université Paris Descartes Paris 5, Paris, France; AP-HP, Hôpital Hôtel-Dieu, Centre de Diagnostic et Thérapeutique, Paris, France; Université Paris Descartes Paris 5, EA 3620, Paris, France; AP-HP, Hôpital Hôtel-Dieu, Service de Pneumologie, Paris, France; AP-HP, Hôpital Hôtel-Dieu, Service de Médecine Interne, Paris, France; Université Paris Descartes Paris 5, Paris, France; AP-HP, Hôpital Cochin, Laboratoire de virologie, Paris, France; AP-HP, Hôpital Bicêtre, Service daccueil des Urgences, Le Kremlin Bicêtre, France; AP-HP, Groupe Hospitalier Bicêtre, Service de medicine interne et maladies infectieuses, Le Kremlin Bicêtre, France; AP-HP, Groupe Hospitalier Bicêtre, Laboratoire de bactério-virologie, Le Kremlin Bicêtre, France; Université Paris-Sud UMR S914, Le Kremlin Bicêtre, France,; INSERM U914, Le Kremlin Bicêtre, France; AP-HP, Hôpital Cochin, Service daccueil des Urgences, Paris, France; Université Paris Descartes Paris 5, Paris, France; AP-HP, Hôpital Cochin, Service de médecine interne et des maladies infectieuses, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service daccueil des urgences, Paris, France; UPMC Univ Paris 06, Paris, France; APHP, Groupe Hospitalier Pitié-Salpêtrière, Laboratoire de Virologie, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Maladies Infectieuses, Paris, France","Conceived and designed the experiments: EC EB FBV DC BR. Performed the experiments: CA EA BB OB EB FBV EC CC Y-EC FD AD GDS SF AGD JG PH CK AK PN BR TT JPV OZ JZ. Analyzed the data: DC AD BE SF. Wrote the paper: FBV EC DC. Conception and design of the study: EC EB FBV DC BR. Provision of study patients: CA EA BB OB EB FBV EC CC Y-EC FD AD GDS SF AGD JG PH CK AK PN BR TT JPV OZ JZ. Data management and statistical analysis: DC AD BE SF. Drafting of the article: FBV EC DC. Interpretation of the data and critical revision of the article for important intellectual content and final approval of the article: EC BB OB CA CC EB FD SF AD BE GDS JPV OZ EA AK JZ JG PN Y-EC TT BR AGD CK PH FBV DC.","No authors of the ANRS URDEP study have any financial or personal relationships with people or organizations that could inappropriately influence this work, although most members of the group have, at some stage in the past, received funding from a variety of pharmaceutical companies for research, travel grants, speaking engagements or consultancy fees: Elisabeth Aslangul has received travel grants from Sanofi Aventis, Pfizer and Bristol-Myers-Squibb. Elisabeth Bouvet, Dominique Costagliola and Jean-Paul Viard have received travel grants, consultancy fees, honoraria and study grants from various pharmaceutical companies, Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck-Sharp & Dohme-Chibret, Roche and ViiV Healthcare. Françoise Brun-Vézinet has received travel grants, consultancy fees and study grants from Gilead Sciences, Janssen, ViiV healthcare and Merck- Sharp & Dohme-Chibret. Enrique Casalino has received travel grants from various pharmaceutical companies, Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck-Sharp & Dohme-Chibret, Roche and ViiV Healthcare. Florence Damond has received travel grants, and honoraria from Merck-Sharp & Dohme-Chibret. Jade Ghosn has received travel grants, honoraria and study grants from various pharmaceutical companies including Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Janssen, Merck-Sharp & Dohme-Chibret, Roche and ViiV Healthcare. Pierre Hausfater has received consultancy fees, honoraria and study grants from biodiagnostic companies, ThermoFisher Scientific, BRAHMS biomarkers, BioMerieux, Radiometer, and Philips. Christine Katlama has received travel grants, honoraria and consultantancy fees from Bristol-Myers-Squibb, Gilead Sciences, Janssen, Merck-Sharp & Dohme-Chibret, and ViiV Healthcare. Bruno Riou has received travel grants, consultancy fees, honoraria and study grants from various pharmaceutical and biomarker companies, Sanofi, Glaxo-Smith-Kline, ThermoFisher Brahms, OctoPharma, LFB, Sangart. Olivier Bouchaud has received travel grants, honoraria and study grants from various pharmaceutical companies, Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-Smith-Kline, Janssen, Merck-Sharp & Dohme-Chibret, Roche, ViiV Healthcare, Sigma Tau, and Novartis. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Enrique Casalino","EC",26,TRUE,5,24,4,3,TRUE,FALSE,FALSE,0,NA,FALSE
